The Canadian Cancer Trials Group (CCTG) has launched a new trial focusing on strengthening the immune system in cancer patients, CCTG IC.8: Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO). Funding and in-kind support, valued (more…)
We are pleased to announce the results of the 2020 ARCC Studentship Competition! Successful Applications The 2020 ARCC Studentship Competition resulted in the approval of 6 awards, with 3 Master’s level recipients, and 3 Doctoral level recipients. ARCC Received a total of 38 submissions for an overall success rate of (more…)
Le français suit INVITATION We invite you to participate in an online survey that asks your opinion about facilitators and barriers to the use of Health Technology Assessment (HTA) in Canada. You can access the survey here: https://maastrichtuniversity.eu.qualtrics.com/jfe/form/SV_71VXNB9baxoMQ8R The study is a collaboration between researchers from Dalhousie University, Maastricht University, (more…)
We are excited to officially launch Virtual ARCC2020! Starting in 2 weeks, on July 22nd, through the end of September, we will host 7 different 1 hour sessions each featuring 2-3 abstracts submitted to ARCC2020. We hope you will consider joining us for some or all of these sessions to (more…)
The McMaster Department of Oncology is seeking a scientist with background and experience in applied data science research or a related field, and a strong interest in joining a multidisciplinary team dedicated to improving the lives of individuals with breast cancer. This is a full time position. The BRIGHT Run (more…)
The Gynecologic Cancer Initiative is excited to present an 8-week webinar series for graduate students and postdoctoral fellows, providing a fulsome overview of the molecular biology, epidemiology, prevention and treatment of all gynecologic cancers. You’ll learn from experts from BC’s Gynecologic Cancer Initiative who will introduce the basics of (more…)
As part of a broader engagement strategy, the CanREValue Collaboration has launched a stakeholder consultation process. In late 2019, the CanREValue Collaboration undertook public stakeholder consultation regarding the Interim Data Report developed by the CanREValue Data Working Group. From this consultation, we received 20 constructive submissions from a diverse set (more…)
ARCC and the CanREValue Collaboration are excited to share our recent study, using Ontario based real-world data to generate real-world evidence on the comparative effectiveness of 2nd line ipilimumab. Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada Dai WF, Beca JM, Croxford (more…)
Lymphoma Canada Research Grants – Deadline April 23, 2021April 14, 2021 - 11:15 am
Chief Executive Officer – Canadian Partnership Against CancerMarch 31, 2021 - 2:24 pm
Updated CanREValue Interim Methods Report + Response to Stakeholder Feedback now available!March 23, 2021 - 10:51 am
Collaboration between CPAC and Statistics Canada results in new data linkageMarch 15, 2021 - 3:18 pm